Drawing for SPHEREMAX

USPTO serial 79188909

SPHEREMAX

Reviewed by CopyMark Law Group

Reg. 5206829Status 404
Filing date
Status date
Registration date
May 23, 2017
Examiner
POLZER, NATALIE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPHEREMAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James A. Oliff

James A. Oliff Oliff PLCP. O. Box 320850Alexandria, VA 22320-4850UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science, namely chemical media additives; chemical preparations for use in industry, namely chemical media additives; chemical preparations for scientific purposes, namely chemical media additives; chemical media additives, other than for medical or veterinary purposes; chemical media additives in kit form, other than for medical or veterinary purposes; chemical media additives for scientific or research purposes, other than for medical or veterinary purposes; chemical media additives in kit form for scientific or research purposes, other than for medical or veterinary purposes; chemical media additives for cell culture, other than for medical or veterinary purposes; chemical media additives for tissue culture, other than for medical or veterinary purposes; chemical media additives for culture of microorganisms, other than for medical or veterinary purposes; media for cell culture for scientific or research purposes, other than for medical or veterinary purposes; media for tissue culture for scientific or research purposes, other than for medical or veterinary purposes; media for culture of microorganisms for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional cell culture for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional tissue culture for scientific or research purposes, other than for medical or veterinary purposes; media for three-dimensional culture of microorganisms for scientific or research purposes, other than for medical or veterinary purposes; media for cell culturing for laboratory use; dispersing agents; chemical media additives for use in separation of cells, other than for medical or veterinary purposes; media for cell culture in kit form for scientific or research purposes, other than for medical or veterinary purposes; media for tissue culture in kit form for scientific or research purposes, other than for medical or veterinary purposes; media for culture of microorganisms in kit form for scientific or research purposes, other than for medical or veterinary purposes; all of the above not including reagents and diagnostic materialsSECTION 71 - CANCELLED—
005Pharmaceutical preparations for use in regenerative medicine, oncology and hematology; pharmaceutical preparations for the treatment of viral and infectious diseases, autoimmune diseases, kidney diseases, hepatic diseases, neurological diseases and bone diseases; chemical media additives for medical or veterinary purposes; chemical media additives in kit form for medical or veterinary purposes; chemical media additives for cell culture, for medical or veterinary purposes; chemical media additives for tissue culture, for medical or veterinary purposes; chemical media additives for culture of microorganisms, for medical or veterinary purposes; culture media for use in regenerative medicine, oncology, hepatology and hematology; culture media for augmentation of bone and other tissues for medical purpose using iPS/ES cells and other stem cells; culture media for use to produce biomedicine, in particular antibody medicines and vaccine medicines; culture media of microorganisms for medical use; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; all of the above not including reagents and diagnostic materialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 13, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 12, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 8, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 20, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 20, 2024INPCINVALIDATION PROCESSED—
Aug 9, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 8, 2023C71TCANCELLED SECTION 71—
May 23, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 13, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 20, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 25, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 25, 2017FIMPFINAL DISPOSITION PROCESSED—
Aug 23, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 23, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 7, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2017GPNXNOTIFICATION PROCESSED BY IB—
Feb 15, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 15, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 19, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 19, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 19, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2016RFNTREFUSAL PROCESSED BY IB—
Jul 19, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 19, 2016RFRRREFUSAL PROCESSED BY MPU—
Jul 19, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 19, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 17, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2016DOCKASSIGNED TO EXAMINER—
Jul 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 14, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 14, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance